Tag Archives: COPD

Keeping Up-to-Date on COPD Controversies: A Clinician Interview

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) aims to increase awareness and research regarding chronic obstructive pulmonary disease (COPD), with the overarching goal of improving COPD prevention, diagnosis, and treatment. The GOLD annual report provides recommendations for COPD management; however, the scientific committee responsible for developing these recommendations notes that there are still… Read More »

Distinct COPD Subgroup Identified by Airway Epithelial IL-17 Response

November 22, 2018 Share this content: The IL-17 response is associated with increases in airway neutrophils and macrophages and is related to worse clinical outcomes in current and former smokers. Gene expression of airway epithelial interleukin (IL)-17 response distinguishes a biologically, radiographically, and clinically distinct chronic obstructive pulmonary disease (COPD) subgroup of patients who may… Read More »

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD)

Home News New Drugs FDA Approves Yupelri FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD) Print this page November 09, 2018 — Today, the U.S. Food and Drug Administration (FDA) approved Yupelri (revefenacin) Inhalation Solution for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Revefenacin is a long-acting muscarinic antagonist… Read More »